L-Glutamic acid
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


L-Glutamic acid
Description:
L-Glutamic acid is an excitatory amino acid neurotransmitter that acts as an agonist for all subtypes of glutamate receptors (metabolic rhodophylline, NMDA, and AMPA) . L-Glutamic acid has an agonist effect on the release of DA from dopaminergic nerve endings. L-Glutamic acid can be used in the study of neurological diseases. L-Glutamic acid acts at ionotropic and metabotropic glutamate receptors[1][2][3][4][5].UNSPSC:
12352211Hazard Statement:
H302, H315, H319, H335Target:
Apoptosis; Endogenous Metabolite; Ferroptosis; iGluRType:
Natural ProductsRelated Pathways:
Apoptosis; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal SignalingApplications:
Neuroscience-NeurodegenerationField of Research:
Neurological DiseaseAssay Protocol:
https://www.medchemexpress.com/_S_-Glutamic_acid.htmlConcentration:
10mMPurity:
99.93Solubility:
DMSO : < 1 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : 6.25 mg/mL (ultrasonic)Smiles:
OC(CC[C@H](N)C(O)=O)=OMolecular Formula:
C5H9NO4Molecular Weight:
147.13Precautions:
H302, H315, H319, H335References & Citations:
[1] Liberatore F, et al. Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration. Neuroscience. 2017 Nov 5;363:142-149.|[2]Giorguieff MF, et al. Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices. Neurosci Lett. 1977 Oct;6 (1) :73-7.|[3]Boga Pekmezekmek A, et al. L-Glutamic acid monosodium salt reduces the harmful effect of lithium on the development of Xenopus laevis embryos. Environ Sci Pollut Res Int. 2020 Nov;27 (33) :42124-42132.|[4]Croce N, et al. Hydrochloric acid alters the effect of L-glutamic acid on cell viability in human neuroblastoma cell cultures. J Neurosci Methods. 2013 Jul 15;217 (1-2) :26-30.|[5]Salyha N, et al. Protective role of l-glutamic acid and l-cysteine in mitigation the chlorpyrifos-induced oxidative stress in rats. Environ Toxicol Pharmacol. 2018 Dec;64:155-163.Shipping Conditions:
Room TemperatureStorage Conditions:
Store at room temperature 3 yearsScientific Category:
Natural ProductsClinical Information:
LaunchedIsoform:
AMPA Receptor; Human Endogenous Metabolite; Microbial MetaboliteCitation 01:
Adv Sci (Weinh) . 2024 Dec 16:e2411479.|Adv Sci (Weinh) . 2025 Oct 5:e11194.|Amino Acids. 2024 Sep 18;56 (1) :56.|Cancer Immunol Immunother. 2025 Jun 7;74 (8) :240.|J Inflamm Res. 2025 Jan 27:18:1235-1254.|J Transl Med. 2024 Feb 18;22 (1) :178.|Nature. 2025 Jul;643 (8070) :192-200.|Neurochem Int. 2023 Oct:169:105587.|Neuropharmacology. 2025 Jun 15:271:110405.|Redox Biol. 2024 May:71:103112.|Res Sq. 2024 Jun 03.|Res Sq. 2024 May 20.CAS Number:
[56-86-0]
